Privia Health EBITDA 2020-2025 | PRVA
Privia Health ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Privia Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $24 |
| 2023 | $27 |
| 2022 | $-14 |
| 2021 | $-215 |
| 2020 | $27 |
| 2019 | $18 |
| Privia Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $7 |
| 2024-12-31 | $7 |
| 2024-09-30 | $8 |
| 2024-06-30 | $7 |
| 2024-03-31 | $3 |
| 2023-12-31 | $3 |
| 2023-09-30 | $7 |
| 2023-06-30 | $9 |
| 2023-03-31 | $8 |
| 2022-12-31 | $3 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-3 |
| 2022-03-31 | $-10 |
| 2021-12-31 | $-18 |
| 2021-09-30 | $-12 |
| 2021-06-30 | $-193 |
| 2021-03-31 | $8 |
| 2020-12-31 | $5 |
| 2020-09-30 | $9 |
| 2020-06-30 | $7 |
| 2020-03-31 | $7 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.768B | $1.736B |
| Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.108B | 58.66 |
| Hims & Hers Health (HIMS) | United States | $12.792B | 132.91 |
| Tempus AI (TEM) | United States | $12.331B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.644B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.793B | 59.27 |
| Hinge Health (HNGE) | United States | $2.732B | 0.00 |
| Enovis (ENOV) | United States | $1.845B | 10.28 |
| Schrodinger (SDGR) | United States | $1.676B | 0.00 |
| Phreesia (PHR) | United States | $1.584B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.491B | 0.00 |
| Omnicell (OMCL) | United States | $1.403B | 24.74 |
| Azenta (AZTA) | United States | $1.392B | 64.70 |
| 10x Genomics (TXG) | United States | $1.303B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.639B | 0.00 |
| Claritev (CTEV) | United States | $0.620B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.603B | 0.00 |
| Talkspace (TALK) | United States | $0.502B | 150.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| Outset Medical (OM) | United States | $0.359B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 792.33 |
| Health Catalyst (HCAT) | United States | $0.277B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.258B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.48 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |